Evidence map›Paper›PMID 21050240›Full record

ArticleAlimentary pharmacology & therapeutics2010

Practice patterns for the evaluation and treatment of eosinophilic oesophagitis.

A F Peery, N J Shaheen, E S Dellon

Open access · bronzeAbstract read
In one paragraph

Article in Alimentary pharmacology & therapeutics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 66 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Practice patterns and adherence to clinical guidelines for diagnosis and management of eosinophilic esophagitis among gastroenterologists.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2020
    Article
  12. Article
  13. Review
  14. Management of eosinophilic esophagitis is often discordant with guidelines and not patient-centered: results of a survey of gastroenterologists.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2019
    Article
  15. Article
  16. Clinical and Molecular Factors Associated With Histologic Response to Topical Steroid Treatment in Patients With Eosinophilic Esophagitis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2019
    Article
  17. A diagnosis of eosinophilic esophagitis is associated with increased life insurance premiums.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2018
    Article
  18. Article
  19. Eosinophilic Esophagitis in Children.Current allergy and asthma reports · 2017
    Review
  20. Role of Endoscopy in Diagnosis and Management of Pediatric Eosinophilic Esophagitis.Gastrointestinal endoscopy clinics of North America · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

A F PeeryCenter for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, 27599-7080, USA.
N J Shaheen
E S Dellon
University of North Carolina at Chapel Hill · US

Funding

UNC Clinical Translation Science Award-K12 Scholars Program (KL2)KL2RR025746 · NCRR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2008 to 2011
$9.0M
DIGESTIVE DISEASES EPIDEMIOLOGY TRAINING PROGRAMT32DK007634 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROBERT S. SANDLER · 1990 to 2026
$7.4M
NCRR NIH HHS KL2 RR025746NCRR NIH HHS KL2RR025746NIDDK NIH HHS T32 DK007634NIDDK NIH HHS T32 DK 07634
6 · The paper itself

Abstract

backgroundAlthough consensus guidelines for eosinophilic oesophagitis have been published, it remains unclear whether gastroenterologists follow these recommendations.

aimTo assess academic and community practice patterns for the evaluation and treatment of eosinophilic oesophagitis and to compare these practices with current guidelines.

methodsThis was a prospective study of academic and community gastroenterologists using a self-administered online survey.

resultsA total of 60% (34 of 57) of academic and 29% (38 of 133) of community gastroenterologists completed the survey. Only 24% of academic and 3% of community gastroenterologists follow consensus guidelines to diagnose eosinophilic oesophagitis (P = 0.007). A proton pump inhibitor trial or negative pH study prior to diagnosis was required by just 25% of all gastroenterologists. A majority (60%) do not use the recommended threshold of 15 eosinophils per high powered field to diagnosis eosinophilic oesophagitis. Half (51%) mistakenly require a positive endoscopic finding. For first-line treatment, about half of the gastroenterologists surveyed treat with a swallowed topical steroid (53% academic, 56% community; P = N.S.), consistent with the guidelines.

conclusionsThere is variability in practice patterns for both diagnosis and treatment of eosinophilic oesophagitis. Ongoing education and research concerning diagnosis and treatment are needed.

Indexed as

Attitude of Health PersonnelAcademic Medical CentersAdrenal Cortex HormonesCommunity Health ServicesEsophagitisGastroenterologyGuideline AdherenceHumansInternetPractice Guidelines as TopicProspective StudiesProton Pump InhibitorsSurveys and QuestionnairesAdrenal Cortex HormonesProton Pump Inhibitors

Identifiers

PMID21050240
PMCPMC3099135
OpenAlexW1493656973

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.